From the Founder — Shymeriae Biotechnology

Founded in May 2025, SHYMERIAE Biotechnology is dedicated to the discovery, development, and advanced biomanufacturing of indigenous probiotic strains.

Committed to sustainable operational excellence and strict adherence to global regulatory standards, our scientific infrastructure — expert biologists, pharmacists, chemists, and bioengineers — positions us as a premier domestic source of engineered probiotic cultures and an alternative to import dependency.

The domestic biomanufacturing of probiotics transcends the mere supply of raw materials for nutraceuticals, cosmetics, or industrial applications; it is a strategic imperative for National Public Health, a cornerstone of Innovation Policy, and a critical high-technology initiative.

— Chairperson of the Board